Home Cart Sign in  
Chemical Structure| 616204-22-9 Chemical Structure| 616204-22-9

Structure of Argireline
CAS No.: 616204-22-9

Chemical Structure| 616204-22-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Argireline is a non-toxic, antiwrinkle peptide that emulates the action of currently used BoNTs.

Synonyms: Acetyl hexapeptide-3

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Argireline

CAS No. :616204-22-9
Formula : C34H60N14O12S
M.W : 888.99
SMILES Code : N=C(N)NCCC[C@@H](C(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCC(N)=O)NC([C@H](CCSC)NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC(C)=O)=O)=O)=O)=O)=O
Synonyms :
Acetyl hexapeptide-3
MDL No. :MFCD09842097

Safety of Argireline

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00942851 Focal Dystonia Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01750346 - Terminated - -
NCT01750346 Focal Dystonia Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02597777 Oily Skin Not Applicable Completed - United States, California ... More >> UC Davis Department of Dermatology Sacramento, California, United States, 95816 Less <<
NCT01381484 Wrinkles Phase 3 Completed - Thailand ... More >> Department of dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University Bangkoknoi, Bangkok, Thailand, 10700 Less <<
NCT00942851 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.12mL

0.22mL

0.11mL

5.62mL

1.12mL

0.56mL

11.25mL

2.25mL

1.12mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records